MARK4
Top inhibitors
| Drug | Inhibition % | Gini |
|---|---|---|
| Midostaurin | 97.9 | 0.50 |
| Brigatinib | 91.8 | 0.51 |
| Defactinib | 83.0 | 0.45 |
| Sunitinib | 72.3 | 0.52 |
| Repotrectinib | 70.9 | 0.61 |
| Axitinib | 65.6 | 0.69 |
| Baricitinib | 64.2 | 0.62 |
| Fedratinib | 56.9 | 0.58 |
| Bosutinib | 52.4 | 0.55 |
| Upadacitinib | 51.6 | 0.66 |
| Crizotinib | 45.3 | 0.58 |
| Pemigatinib | 42.9 | 0.72 |
| Nintedanib | 37.5 | 0.61 |
| Ruxolitinib | 33.6 | 0.59 |
| Abrocitinib | 32.8 | 0.58 |
Known variants
No variants catalogued.